Previous Close | 34.16 |
Open | 34.73 |
Bid | 33.51 x 200 |
Ask | 33.64 x 300 |
Day's Range | 33.23 - 34.90 |
52 Week Range | 17.53 - 59.84 |
Volume | |
Avg. Volume | 911,209 |
Market Cap | 2.579B |
Beta (5Y Monthly) | 0.67 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences:
PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced a corporate update and financial results for the first quarter ending March 31, 2024.
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 19, 2024, the company approved non-statutory stock options to purchase an aggregate of 8,090 shares of its common stock and 8,290 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to six new employees. The awards were made pursuant to the Nasdaq inducement grant exception as a component of the new hires' employment compensation.